Though funding models vary throughout the healthcare industry, one revenue source remains constant: the charitable gift.
Category: ROOT
What growth will look like for Virginia Mason Franciscan Health in 2025
Ketul Patel, CEO of Tacoma, Wash.-based Virginia Mason Franciscan Health, is driving improvements in community health through expanded care, strategic partnerships and a focus on workplace culture.
Top 25 health systems' most-successful digital projects of '24
Health systems experienced another year of digital advancement in 2024, with more big EHR moves and a push toward generative AI.
Developer of hospital-targeting ransomware faces charges
A dual Russian-Israeli national has been charged in connection with the LockBit ransomware group, which has targeted thousands of victims worldwide, including hospitals.
Fred Hutch Cancer Center leader to retire
Seattle-based Fred Hutch Cancer Center leader, John Thompson, MD, is retiring at year’s end after serving at the organization for 40 years.
Karmanos institute 1st to treat liver cancer with at-home device
Detroit-based Wayne State University’s Barbara Ann Karmanos Cancer Institute is the first facility in the world to prescribe a new at-home liver cancer treatment.
Respiratory illnesses surge: 5 updates
Fourteen states and Washington, D.C., are experiencing high or very high levels of respiratory illness, with influenza, COVID-19 and respiratory syncytical virus all contributing to increased healthcare visits across the U.S.
NFL legend faces GI cancer
Former wide receiver Randy Moss underwent surgery and spent six days in the hospital due to cancer discovered in his bile duct, in between the pancreas and liver, according to a Dec. 14 report from NBC News.
2024's major GI partnerships
Here are 16 notable gastroenterology partnerships to know since the beginning of 2024:
FDA: No more need for compounded versions of Mounjaro, Zepbound
The FDA has declared the end of the two-year shortages of Eli Lilly’s Mounjaro and Zepbound — used to treat diabetes and weight loss, respectively — and has reaffirmed its decision to halt the production of compounded versions of the drugs, Bloomberg r…
